Veterinary Hematology Analyzers Market Report 2026

Veterinary Hematology Analyzers Market Overview

• Veterinary Hematology Analyzers market size has reached to $1.04 billion in 2025 • Expected to grow to $1.53 billion in 2030 at a compound annual growth rate (CAGR) of 8.1% • Growth Driver: Zoonotic Disease Prevalence Drives Veterinary Hematology Analyzer Market Growth • Market Trend: Introduction Of Cutting-Edge Technologies In The Veterinary Hematology Analyzers Market • North America was the largest region in 2025.

What Is Covered Under Veterinary Hematology Analyzers Market?

A veterinary hematology analyzer is a device used in animal healthcare to produce a complete blood count (CBC) or hemogram. It analyzes the blood's produced constituents quantitatively and qualitatively, including red blood cells (erythrocytes), white blood cells (leukocytes), and platelets (thrombocytes). Hematology analyzers are used in the medical profession to perform white blood cell counts, complete blood counts, reticulocyte analyses, and coagulation assays on blood samples. The main types of veterinary hematology analyzers are table-top analyzers and point-of-care analyzers. A tabletop analyzer is a laboratory instrument used to test samples of different compounds. They are available for companion animals and livestock. They use various analysis parameters such as 2-part WBC differential, 3-part WBC differential, 5-part WBS differential, and others, and are utilized by various end-users such as research institutes, veterinary hospitals and clinics, veterinary diagnostic centers, point-of-care testing, in-house testing, and others.

What Is The Veterinary Hematology Analyzers Market Growth Forecast?

The veterinary hematology analyzers market size is expected to see strong growth in the next few years. It will grow to $1.53 billion in 2030 at a compound annual growth rate (CAGR) of 8.1%. The growth in the forecast period can be attributed to expansion of point-of-care analyzers for field use, integration of predictive analytics in veterinary labs, growth in portable handheld analyzers, increased demand for multi-parameter blood analysis, adoption of cloud-based data management for hematology testing. Major trends in the forecast period include automation in hematology analysis, portable and point-of-care testing, advanced multi-parameter blood analysis, remote data integration for veterinary labs, predictive analytics for animal health.

Global Veterinary Hematology Analyzers Market Segmentation

1) By Product Type: Table Top Analyzer, Point Of Care Analyzer 2) By Animal Type: Companion Animal, Livestock Animals 3) By Analysis Parameter: 2-Part WBC Differential, 3-Part WBC Differential, 5-Part WBS Differential, Other Analysis Parameters 4) By End-Users: Research Institutes, Veterinary Hospitals And clinics, Veterinary Diagnostics Centers, Point-of-care Testing, Inhouse-Testing, Other End-Users Subsegments: 1) By Table Top Analyzer: Fully Automated, Semi-Automated 2) By Point Of Care Analyzer: Handheld Analyzers, Portable Analyzers For Field Use

What Is The Driver Of The Veterinary Hematology Analyzers Market?

The increasing prevalence of zoonotic diseases in animals is expected to propel the growth of the veterinary hematology analyzer market going forward. A zoonotic disease is an infectious disease caused by harmful microorganisms such as bacteria, viruses, fungi, and parasites that are spread between animals and humans. Veterinary hematology analyzers can detect anomalies in blood parameters in real time, allowing veterinarians to quickly identify zoonotic infections, commence appropriate treatment, and adopt essential preventative measures to keep them from spreading. For instance, in February 2023, according to the Council on Foreign Relations, a US-base think-tank organization, it is estimated that 60 percent of known infectious diseases and as much as 75 percent of new or emerging infectious diseases (EIDs) are zoonotic in origin. Therefore, the growing prevalence of zoonotic disease in animals drives the veterinary hematology analyzers industry.

Key Players In The Global Veterinary Hematology Analyzers Market

Major companies operating in the veterinary hematology analyzers market are Zoetis Services LLC, IDEXX Laboratories Inc., Heska Corporation, Scil Animal Care Company GmbH, Shenzhen Mindray Bio-Medical Electronics Co. Ltd., HORIBA Medical, Sysmex Corp., Boule Diagnostics AB, Diatron Mi Apac Private Limited, Rayto Life and Analytical Sciences Co. Ltd., Shezhen Dymind Biotechnology Co. Ltd., AniTech Diagnostics Inc., Clindiag Systems Co. Ltd., Labomed Inc., Neomedica, New Gen Medical Systems, PZ Cormay S.A., Quadratech Diagnostics Ltd., Agappe Diagnostics Ltd., Melet Schloesing Laboratoires, Orphee SA, Eurolyser Diagnostica GmbH, Hycel Handelsgesellschaft, Gesan Production, Menarini Diagnostics, Nihon Kohden Europe, Shenzhen Icubio Biomedical Technology

Global Veterinary Hematology Analyzers Market Trends and Insights

Major companies operating in the veterinary hematology analyzers market are increasing their focus on introducing advanced blood analyzers, such as the ST-200 CC Blood Gas Analyzer-Ultra Smart, to gain a competitive edge in the market. The ST-200 CC Blood Gas Analyzer-Ultra Smart is a medical device that offers advanced and precise testing capabilities for blood gas analysis in critical care settings, enhancing diagnostic accuracy and efficiency. For instance, in September 2024, Zoetis Inc., a US-based Drug company, producer of medicine and vaccinations for pets and livestock, introducing the Vetscan OptiCell, the first cartridge-based AI-powered hematology analyzer designed specifically for veterinary use. to greatly improve veterinary diagnostics by utilizing cutting-edge technology. Through the provision of sophisticated Complete Blood Count (CBC) analysis with lab-quality accuracy at the point of care, this ground-breaking technology seeks to improve veterinary diagnostics. By integrating advanced AI image identification for more accurate blood cell characterization, cutting expenses and space needs, and providing prompt and dependable results, the Vetscan OptiCell is intended to increase productivity in veterinary clinics.

What Are Latest Mergers And Acquisitions In The Veterinary Hematology Analyzers Market?

In June 2023, Mars Incorporated, a US-based supplier of animal care services, acquired Heska Corporation for an undisclosed sum. With this acquisition, Mars expanded its portfolio of diagnostics and technology, accelerating research and developments, innovation, and better serving more veterinary professionals and pets. Heska Corp. is a US-based company that develops innovative veterinary hematology analyzers to improve the quality of animal healthcare.

Regional Outlook

North America was the largest region in the veterinary hematology analyzer market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Veterinary Hematology Analyzers Market?

The veterinary hematology analyzer market consists of sales of manual, semi-automated, and fully automated hematology analyzers. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.